Explore Pitches
Discover & Share News, Products & Promotions
Apple and Hammacher Store Sales Should Boost AltiGen’s iFusion Revenue
iFusion iPhone Product Now Available at Apple Store and Hammacher Schlemmer
Sales of AltiGen Communications’ (OTCQX:ATGN) could be getting a shot in the arm for the remainder of this quarter and in upcoming quarters as their revolutionary iFusion SmartStation is now available at the Apple, Inc.’s (NASDAQ:AAPL) Apple Store (http://store.apple.com/us/product/H7939VC/A/altigen-ifusion-smartstation-dock-for-iphone) and the uber-popular Hammacher Schlemmer website (http://www.hammacher.com/Produc…
ecoTECH Energy Preps for Site Construction of Eco-Industrial Complex and Receives $55 Million Debt Financing
Company on Path to Profitability with Green Technologies
In preparation for what will be one of the most advanced complexes of its type in North America, ecoTECH Energy Group, Inc. (OTCBB:ECTH) has begun to clear the McBride, British Columbia Lamming Mills site for its Aquaponics and Combined Heat and Power (CHP) facility that is slated for construction this Spring. The Canadian Ministry of Forests and Range has granted ecoTECH its Timber Mark Certificate and a local logging company has been contracted to selectively cut enough trees to allow room for the development, whilst retaining as many trees as possible on the site.
500 Million or 1 in 10 Adults Will Have Diabetes by 2030
International Diabetes Federation anticipates a 50 percent rise in people living with diabetes in next two decades.
The International Diabetes Federation (IDF) is the umbrella organization of over 200 national diabetes associations in over 160 countries. It represents the interests of the growing number of people with diabetes and those at risk. The Federation has been leading the global diabetes community since 1950, and IDF’s mission is to promote diabetes care, prevention, and a cure worldwide.
Medicare and Medicaid Waste in Focus as CMS Administrator Departs Position
The New York Times published an article this past weekend titled, “Health Official Takes Parting Shot at Waste.” Written by Robert Pear, the article focuses on commentary from Dr. Donald M. Berwick, the newly departed former administrator of the Centers for Medicare and Medicaid Services (CMS).
New Technologies to Contain Waste in Diabetes Test Supplies
Opportunity for Medicare to Reduce Millions in Costs
At the same time that the federal government seeks to cut Medicare spending, awareness is growing about a fraudulent practice around diabetes test strips that is running up program costs and putting the health of patients at risk.
The “Green Revolution” Driving Investors to ecoTECH Energy
The need to cut usage of fossil fuels, so-call "brown energy," is not exactly a new concept. Over the last three decades, U.S. governments have spent roughly $40 billion promoting the use of alternative energies. Today, the "green revolution" is beginning to hit its stride through not only a global social consciousness, but also through a more legislative approach as well. The nascent mandates will have people and businesses not only be operating in a more environmentally-friendly fashion because they want to, but because they have to as a result of a political boom towards green energy.
Profire Energy (PFIE): Triple Digit Growth in the Third Quarter
Revenue and Net Income Surge
Profire Energy Inc. (OTCBB: PFIE) is an innovative provider of safe and efficient burner management systems and services for use in oilfield combustion, with customers like Devon Energy Corporation (NYSE: DVN) and EnCana Corporation (NYSE: ECA), as well as smaller “mom and pop” oil and gas exploration and development companies.
Cellceutix Files IND for New Cancer Drug Clinical Trials
Planned Clinical Trials to be Hosted by Dana-Farber and Beth Israel Deaconess Medical Center
Cellceutix Corporation (OTCBB:CTIX) ("the Company"), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat unmet medical conditions, is pleased to report that the Company has filed its Investigational New Drug (IND) application for Kevetrin™, a novel anti-cancer drug, with the U.S. Food and Drug Administration (FDA). The Company must now wait 30 calendar days before initiating the clinical trial. During this time, the FDA reviews the data in the IND and determines the conditions under which human trials can commence.
Brekford Produces Strong Numbers in Q3, Profits Up More than 100 Percent
Sales, Income, Profit and Profit Margins Climb
Brekford Corporation (OTCBB:BFDI) released financial information from its third fiscal quarter 2011 this morning. The Hanover, Maryland-based technology service provider showed the type of growth that investors want to see with revenue climbing 100.7 percent, gross profit surging by 162.4 percent and net profit jumping upward by an alarming 1,311.7 percent.